• 1
    Raynor DK. The influence of written information on patient knowledge and adherence to treatment. In: MyersL, MidenceK (eds) Adherence to Treatment in Medical Conditions. London: Harwood Academic, 1998: 83111.
  • 2
    Coulter A. The Autonomous Patient: Ending Paternalism in Medical Care. London: The Nuffield Trust, 2002.
  • 3
    Department of Health. The Expert Patient: A New Approach to Chronic Disease Management for the 21st Century. London: Department of Health, 2001.
  • 4
    Department of Health. Better Information, Better Choices, Better Health; Putting Information at the Centre of Health. London: Department of Health, 2004.
  • 5
    Dickinson D, Raynor DK. Ask the patients – they may want to know more than you think. British Medical Journal, 2003; 327: 861.
  • 6
    Arthur VAM. Written patient information: a review of the literature. Journal of Advanced Nursing, 1995; 21: 10811086.
  • 7
    Coulter A, Entwistle V, Gilbert D. Informing Patients an Assessment of the Quality of Patient Information Materials. London: King’s Fund Publishing, 1998.
  • 8
    Coulter A, Magee H. The European Patient of the Future. Maidenhead: Open University Press, 2003.
  • 9
    Garlick W. Patient Information: What’s the Prognosis? London: Consumers Association, 2003.
  • 10
    Raynor DK, Savage I, Knapp P, Henley J. We are the experts: people with asthma talk about their medicine information needs. Patient Education & Counseling, 2004; 53: 167174.
  • 11
    Britten N, Stevenson FA, Barry CA, Barber N, Bradley CP. Misunderstandings in prescribing decisions in general practice: a qualitative study. British Medical Journal, 2000; 320: 484488.
  • 12
    Stevenson FA, Barry CA, Britten N, Barber N, Bradley CP. Doctor patient communication about drugs: the evidence for shared decision making. Social Science and Medicine, 2000; 50: 829840.
  • 13
    Rycroft-Malone J, Latter S, Yerrell P, Shaw D. Consumerism in health care: the case of medication information. Journal of Nursing Management, 2001; 9: 221230.
  • 14
    Pollock K. Concordance in Medical Consultations – A Critical Review. UK: Radcliffe Publishing, 2005.
  • 15
    Raynor DK, Blenkinsopp A, Knapp P et al. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technology Assessment, 2007; 11: 1178.
  • 16
    Morris L, Halperin J. Effects of written drug information on patient knowledge and compliance: a literature review. American Journal Public Health, 1979; 69: 4752.
  • 17
    Kenny T, Wilson RG, Purves IN et al. A PIL for every ill? Patient Information Leaflets (PILs): a review of past, present, and future use. Family Practice, 1998; 15: 471479.
  • 18
    Koo M, Krass I, Aslani P. Factors influencing consumer use of written drug information. Annals Pharmacotherapy, 2003; 32: 259267.
  • 19
    Buck M. Providing patients with written medication information. Annals Pharmacotherapy, 1998; 32: 962969.
  • 20
    Greenhalgh T, Robert G, Bate P, Kyriakidou O. Diffusion of innovations in service organisations: systematic review and recommendations. The Millbank Quarterly, 2004; 82: 581629.
  • 21
    Herxheimer A. Leaflets with NSAIDs do not warn users clearly – a UK survey. Pharmaceutical Journal, 1999; 262: 559561.
  • 22
    Hughes L, Whittlesea C, Luscombe D. Patients’ knowledge and perceptions of the side-effects of OTC medication. Journal of Clinical Pharmacy and Therapeutics, 2002; 27: 243248.
  • 23
    Cedraschi C, Piguet V, Allaz AF, Desmeules J, Dayer P. Patient information leaflets and antidepressant prescription in chronic pain patients. Progress in Pain Research and Management, 2000; 16: 887895.
  • 24
    Grime J, Pollock K. Information vs. experience: a comparison of an information leaflet on antidepressants with lay experience of treatment. Patient Education & Counseling, 2004; 54: 361368.
  • 25
    Koo M, Krass I, Aslani P. Consumer opinions on medicines information and factors affecting its use – An Australian experience. International Journal of Pharmacy Practice, 2002; 10: 107114.
  • 26
    Nair K, Dolovich L, Cassels A et al. What patients want to know about their medications: focus group study of patient and clinician perspectives. Canadian Family Physician, 2002; 48: 104110.
  • 27
    Pollock K, Grime J, Baker E, Mantala K. Meeting the information needs of psychiatric inpatients: staff and patient perspectives. Journal of Mental Health (UK), 2004; 13: 389401.
  • 28
    Dixon-Woods M, Agarwal S, Young B, Jones D, Sutton A. Integrative Approaches to Qualitative and Quantitative Evidence. London: Health Development Agency, 2004.
  • 29
    Bandesha G, Raynor DK, Teale C. Preliminary investigation of patient information leaflets as package inserts. International Journal of Pharmacy Practice, 1996; 4: 246248.
  • 30
    Blom AT, Rens JA. Information about over-the-counter medication: the role of the pharmacy. Patient Education & Counseling, 1989; 14: 181189.
  • 31
    De Tullio PL, Eraker SA, Jepson C et al. Patient medication instruction and provider interactions: effects on knowledge and attitudes. Health Education Quarterly, 1986; 13: 5160.
  • 32
    Jazieh AR, Brown D. Development of a patient information packet for veterans with cancer receiving chemotherapy. Journal of Cancer Education, 1999; 14: 9698.
  • 33
    Morris LA, Mazis M, Gordon E. A survey of the effects of oral contraceptive patient information. JAMA, 1977; 238: 25042508.
  • 34
    Mottram DR, Reed C. Comparative evaluation of patient information leaflets by pharmacists, doctors and the general public. Journal of Clinical Pharmacy and Therapeutics, 1997; 22: 127134.
  • 35
    Raynor DK, Knapp P. Do patients see, read and retain the new mandatory medicines information leaflets? Pharmaceutical Journal, 2000; 264: 268270.
  • 36
    Vander Stichele RH, Van Haecht CH, Braem MD, Bogaert MG. Attitude of the public toward technical package inserts for medication information in Belgium. DICP, 1991; 25: 10021006.
  • 37
    Berry D, Gillie T, Banbury S. What do patients want to know: an empirical approach to explanation generation and validation. Expert Systems with Applications, 1995; 8: 419428.
  • 38
    Fisher S, Mansbridge B, Lankford A. Public judgments of information in a diazepam patient package insert. Archives of General Psychiatry, 1982; 39: 707711.
  • 39
    Keown C, Slovic P, Lichtenstein S. Attitudes of physicians, pharmacists, and laypersons toward seriousness and need for disclosure of prescription drug side effects. Health Psychology, 1984; 3: 111.
  • 40
    Miselli M. What information for the patient? Large scale pilot study on experimental package inserts giving information on prescribed and over the counter drugs. British Medical Journal, 1990; 301: 12611265.
  • 41
    Coulter A, Entwistle V, Gilbert D. Sharing decisions with patients: is the information good enough? British Medical Journal, 1999; 318: 318322.
  • 42
    Ross BS, Potter LS, Armstrong KA. Improving patient educational literature: an understandable patient package insert for ‘the pill’. Journal of Obstetric, Gynecologic, and Neonatal Nursing, 2004; 33: 198208.
  • 43
    Thompson S, Stewart K. Older persons’ opinions about, and sources of, prescription drug information. International Journal of Pharmacy Practice, 2001; 9: 153162.
  • 44
    Vander Stichele RH, De Potter B, Vyncke P, Bogaert MG. Attitude of physicians towards patient package inserts for medication information in Belgium. Patient Education & Counseling, 1996; 28: 513.
  • 45
    Berry DC, Michas IC, Gillie T, Forster M. What do patients want to know about their medicines, and what do doctors want to tell them? A comparative study. Psychology and Health, 1997; 12: 467480.
  • 46
    Buchbinder R, Hall S, Grant G, Mylvaganam A, Patrick MR. Readability and content of supplementary written drug information for patients used by Australian rheumatologists. Medical Journal of Australia, 2001; 174: 575578.
  • 47
    Dixon-Woods M. Writing wrongs? An analysis of published discourses about the use of patient information leaflets. Social Science and Medicine, 2001; 52: 14171432.
  • 48
    Garrud P, Wood M, Stainsby L. Impact of risk information in a patient education leaflet. Patient Education & Counseling, 2001; 43: 301304.
  • 49
    Stevenson FA, Wallace G, Rivers P, Gerrett D. ‘It’s the best of two evils’: a study of patients’ perceived information needs about oral steroids for asthma. Health Expectations, 1999; 2: 185194.
  • 50
    Nicolson DJ, Knapp P, Raynor DK, Grime J, Pollock K. Do themes in consumer medicines information literature reviews reflect those important to stakeholders? Patient Education & Counseling, 2006; 64: 112118.
  • 51
    Pound P, Britten N, Morgan M et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Social Science and Medicine, 2005; 61: 133155.
  • 52
    Berthelot J-M, Glemarec J, Guillot P, Chiffoleau A, Maugars Y, Rodat O. Informing patients about serious side effects of drugs. A 2001 survey of 341 French rheumatologists. Joint Bone Spine, 2003; 70: 5257.
  • 53
    Ford S, Schofield T, Hope T. Barriers to the evidence based patient choice (EBPC) consultation. Patient Education & Counseling, 2002; 47: 179185.
  • 54
    Smith S, Henderson M. What you don’t know won’t hurt you. Information given to patients about the side effects of antipsychotic drugs. Psychiatric Bulletin, 2000; 24: 172174.
  • 55
    Rogers A, Kennedy A, Nelson E, Robinson A. Uncovering the limits of patient centeredness: Implementing a self-management trial for chronic illness. Qualitative Health Research, 2005; 15: 224239.
  • 56
    Mazis M, Morris LA, Gordon E. Patient attitudes about two forms of printed oral contraceptive information. Medical Care, 1978; 16: 10451054.
  • 57
    Dodds L, King R. Factors affecting attitudes to the provision of information with prescribed drugs. Pharmaceutical Journal, 1989; 242: R7R12.